GBT
Global Blood Therapeutics, Inc.
Delisted
GBT was delisted on the 4th of October, 2022.
213 hedge funds and large institutions have $2.7B invested in Global Blood Therapeutics, Inc. in 2021 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 62 increasing their positions, 96 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
33% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 39
35% less repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 96
Holders
213
Holding in Top 10
6
Calls
$19.8M
Puts
$22.6M
Top Buyers
| 1 | +$93.6M | |
| 2 | +$51.9M | |
| 3 | +$36.1M | |
| 4 |
YCM
Yiheng Capital Management
San Francisco,
California
|
+$29.7M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$29.4M |
Top Sellers
| 1 | -$61M | |
| 2 | -$25.8M | |
| 3 | -$25.1M | |
| 4 |
Brown Advisory
Baltimore,
Maryland
|
-$21.2M |
| 5 |
Goldman Sachs
New York
|
-$17.5M |